In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

Users on Facebook, Instagram and X have shared the same “BREAKING NEWS” message, claiming that “A CURE FOR HIV/AIDS HAS JUST ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Treatment Options Are Available. However, just because a person has HIV or an HIV rash doesn’t mean it's the end of the world. In fact, advancements in HIV medical treatment have come such a long way ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...